A Review of the SCD-HEFT, COMPANION, and CARE-HF Trials

  • D. S. Cannom
Conference paper


The past 10 years have provided a series of well-designed clinical trials to study the effect of the implantable cardioverter defibrillator (ICD) in patients at high risk of sudden death. These studies have been carried out on both sides of the Atlantic. Patient populations have been recruited both from post-event populations and from pre-event populations judged to be at high enough risk to warrant prophylactic ICD implantation. The results of both categories of trial have been remarkably similar. Interestingly, the primary prevention studies were both initiated first and have shown more positive impact of ICD implantation on survival than the secondary prevention trials.


Implantable Cardioverter Defibrillator Implantable Cardioverter Defibrillator Therapy Implantable Cardioverter Defibrillator Implantation Multicenter Automatic Defibrillator Implantation Trial Conventional Therapy Group 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M, and the other MADIT investigators (1996) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335:1933–1940PubMedCrossRefGoogle Scholar
  2. 2.
    Moss AI, Fadi Y, Zareba W, Cannom DS, Hall WJ, for the Multicenter Automatic Defibrillator Implantation Trial Research Group (2001) Survival benefit with an implanted defibrillator in relation to mortality risk in chronic coronary heart disease. Am J Cardiol 88:516–520Google Scholar
  3. 3.
    Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G (1999) A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial (MUSTT) Investigators. N Engl J Med 341:1882–1890PubMedCrossRefGoogle Scholar
  4. 4.
    Moss AJ, Zareba W, Hall J, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, for the MADIT-II Investigators (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883Google Scholar
  5. 5.
    Zareba W (2002) Presented at NASPE’s 23rd Annual Scientific Sessions in San Diego on 11 May, 2002 in the Late Breaking Trial Session on MADIT IIGoogle Scholar
  6. 6.
    Bansch D, Antz M, Boczor S, Volkner M, Tebbenjohanns J, Seidl K, Block M, Gietzen F, Berger J, Kuck KH, for the CAT investigators (2002) Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation 105:1453–1458PubMedGoogle Scholar
  7. 7.
    Bristow MR, Feldman AM, Saxon LA, for the COMPANION Steering Committee and COMPANION Clinical Investigators (2000) Heart failure management using implantable devices for ventricular resynchronization: comparison of medical therapy, pacing, and defibrillation in chronic heart failure (COMPANION) trial. J Card Fail 6:276–285Google Scholar
  8. 8.
    Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Klein W, Tavazzi L, on behalf of the CARE-HF study steering committee and investigators (2001) The CARE-HF study (Cardiac REsynchronisation in Heart Failure study): rationale, design and end-points. Eur J Heart Fail 3:481–489PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2003

Authors and Affiliations

  • D. S. Cannom
    • 1
  1. 1.Good Samaritan HospitalLos AngelesUSA

Personalised recommendations